Table 1 Demographic baseline characteristics.
From: Feasibility of alternating induction and maintenance chemotherapy in pancreatic cancer
Characteristics | 5FU/LV maintenance group | Control group |
|---|---|---|
Patients | 13 | 43 |
Age, mean | 62 | 64 |
Age, range | 48–73 | 47–79 |
Male | 9 (69%) | 27 (63%) |
Female | 4 (31%) | 16 (37%) |
ECOG 0–1 | 12 (100%) | 43 (100%) |
Tumor localization | ||
PDAC, head | 7 (54%) | 27 (63%) |
PDAC, other | 6 (46%) | 16 (37%) |
Disease stage | ||
Metachronous metastatic after initial surgery in curative intend with adjuvant gemcitabine | 3 (23%) | 11 (26%) |
Synchronous metastatic | 8 (62%) | 28 (65%) |
Locally advanced | 2 (15%) | 4 (9%) |
